Skip to content ↓

In the Media

Media Outlet:
New York Times
Publication Date:

In an article for The New York Times about how scientists are developing new ways to treat disease using bacteria, Carl Zimmer highlights how MIT startup Synlogic is developing what could be the first FDA-approved synthetic biology-based medical treatment for a disease called phenylketonuria.

Related News